Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2018-03-08
Target enrollment:
Participant gender:
Summary
This trial is conducted globally. The aim of this trial is to investigate Efficacy and Safety
of Oral Semaglutide versus Empagliflozin in Subjects with Type 2 Diabetes Mellitus.